Researchers Use Antibiotic to Modulate Gut Bacteria, Enhance Tumor Drug Delivery
In a series of experiments, the investigators administered a short course of metronidazole, a widely approved antibiotic, to mice bearing various cancer types. The treatment selectively suppressed bile‑acid‑producing microbes, decreasing the chemical signal that prompts liver Kupffer cells to purge drug particles. With the liver’s clearance mechanism dampened, a larger fraction of the nanoparticle‑encapsulated chemotherapy reached the tumor site. The enhanced delivery translated into measurable reductions in tumor size and extended overall survival across several cancer models.